Registration for the 3rd Next Generation Conjugates is now closed!
Explore Related ADC & Engineered Antibodies Products
ADC & Engineered Antibodies
Maximizing the Therapeutic Window of ADCs & Engineered Antibodies
The World ADC Series covers the full breadth and depth of drug conjugates from next-generation conjugates and ADC target selection to ADC analytical development and manufacturing. Our mission is to provide the industry with knowledge and connections to maximize the therapeutic window of drug conjugates.
A manually curated database solution including clinical trials and drug records for preclinical, active, approved and discontinued drugs and treatments developed in partnership with the world’s leading ADC drug developers and academics.
A trusted provider of market intelligence for anyone looking to understand the complexities of ADC and Engineered Antibodies research and development.